Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.
DeFilipp Z, Damania AV, Kim HT, Chia-Chi C, El-Jawahri A, McAfee SL, Bottoms AS, Toncheva V, Smith MM, Dolaher M, Perry LS, White M, Diana B, Connolly S, Dey BR, Frigault MJ, Newcomb RA, O'Donnell PV, Spitzer TR, Mansour MK, Weber D, Ajami NJ, Hohmann E, Jenq RR, Chen YB.
DeFilipp Z, et al. Among authors: perry ls.
Blood Adv. 2024 Mar 12:bloodadvances.2024012556. doi: 10.1182/bloodadvances.2024012556. Online ahead of print.
Blood Adv. 2024.
PMID: 38471063